Risk-Benefit Tightrope for NOAC + DAPT Varies by ACS Type Risk-Benefit Tightrope for NOAC + DAPT Varies by ACS Type

The bleeding-vs-ischemic event balance favored one form of acute coronary syndrome when new oral anticoagulants were added to dual antiplatelet therapy in a meta-analysis of secondary prevention trials.Medscape Medical News

Source: Medscape Medical News Headlines - February 14, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news